Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Dysarthria

ClinicalTrials.gov lists 57 trials for Dysarthria or a narrower condition beneath it. VA Office of Research and Development has the most among industry and government lead sponsors, with 2.

MeSH D004401 Nervous System Diseases C10 C23
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 2/3 Phase 2/3 1 Not applicable Not applicable 42 Observational Observational 13 Phase 1 Phase 1 1 Phase 2/3 Phase 2/3 1 Not applicable Not applicable 42 Observational Observational 13

Trials per phase (log scale)

57 of the 57 trials are tagged with Dysarthria itself; the rest are tagged with a narrower condition beneath it.

Get the Dysarthria report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Dysarthria trials start? (17)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here.

Trials over time, by phase

  • Phase 1
  • Phase 2/3
  • Not applicable
  • Observational

Top of scale: 7

1992: 1 trials (Observational 1) 2002: 1 trials (Not applicable 1) 2006: 1 trials (Phase 1 1) 2013: 1 trials (Not applicable 1) 2014: 3 trials (Observational 1, Not applicable 2) 2015: 2 trials (Not applicable 2) 2016: 4 trials (Observational 1, Not applicable 3) 2017: 4 trials (Not applicable 4) 2018: 3 trials (Observational 2, Not applicable 1) 2019: 3 trials (Observational 1, Not applicable 2) 2020: 3 trials (Observational 1, Not applicable 2) 2021: 7 trials (Observational 2, Not applicable 5) 2022: 3 trials (Observational 1, Not applicable 2) 2023: 5 trials (Not applicable 5) 2024: 3 trials (Not applicable 2, Phase 2/3 1) 2025: 7 trials (Observational 2, Not applicable 5)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 3
2025 7
2024 3
2023 5
2022 3
2021 7
2020 3
2019 3
2018 3
2017 4

No forecast is made for this condition: it averages 4.6 trial starts a year over the five years to September, under the 5 a year the method needs.

Prediction, not a registry value: median of 36 months from start to primary completion across 13 trials still running at the 2026-10-09 snapshot; registered median of 24 months across 25 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Dysarthria trials in? (4)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 2/3 1
Not applicable 42
Observational 13

How many Dysarthria trials are recruiting? (7)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 2
Recruiting 15
Active, not recruiting 4
Completed 24
Terminated 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Dysarthria trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
VA Office of Research and Development 2

Interventions as named in the registry (4)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Patients 1
TMS 1
MRI 1
Treatment As Usual 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Dysarthria? (103)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Smartphone-Based Speech Therapy for Poststroke Dysarthria: Pilot Randomized Controlled Trial Evaluating Efficacy and Feasibility. Journal of medical Internet research 2024 Yes
An Accurate and Rapidly Calibrating Speech Neuroprosthesis. The New England journal of medicine 2024 Yes
The Application of Time-Frequency Masking To Improve Intelligibility of Dysarthric Speech in Background Noise. Journal of speech, language, and hearing research : JSLHR 2023 Yes
Generalized Learning of Dysarthric Speech Between Male and Female Talkers. Journal of speech, language, and hearing research : JSLHR 2021 Yes
Analysing spectral changes over time to identify articulatory impairments in dysarthria. The Journal of the Acoustical Society of America 2021 Yes

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages